Compound: Dibenzepin
SMILES: O=C1N(c2c(cccc2)N(c3c1cccc3)C)CCN(C)C
InChIKey: QPGGEKPRGVJKQB-UHFFFAOYSA-N
Synonyms: Dibenzepin, 4498-32-2, Dibenzepina, Dibenzepinum, 510SJZ1Y6L, DTXSID7022916, 5-[2-(dimethylamino)ethyl]-11-methylbenzo[b][1,4]benzodiazepin-6-one, 11H-Dibenzo[b,e][1,4]diazepin-11-one, 10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-, 11H-Dibenzo(b,e)(1,4)diazepin-11-one, 10-(2-(dimethylamino)ethyl)-5,10-dihydro-5-methyl-, 5-(2-(dimethylamino)ethyl)-11-methylbenzo(b)(1,4)benzodiazepin-6-one, RefChem:132799, DTXCID702916, N06AA08, Dibenzepine, 10-[2-(Dimethylamino)ethyl]-5,10-dihydro-5-methyl-11H-dibenzo[b,e][1,4]diazepin-11-one, Dibenzepin (INN), 10-(2-(Dimethylamino)ethyl)-5-methyl-5H-dibenzo(b,e)(1,4)diazepin-11(10H)-one, 5,10-Dihydro-10-(2-(dimethylamino)ethyl)-5-methyl-11H-dibenzo(b,e)(1,4)diazepin-11-one, 5H-Dibenzo(b,e)(1,4)diazepin-11(10H)-one, 10-(2-(dimethylamino)ethyl)-5-methyl-, DIBENZEPIN [INN], Ecatril hydrochloride, 11H-Dibenzo(b,e)(1,4)diazepin-11-one, 5,10-dihydro-10-(2-(dimethylamino)ethyl)-5-methyl-, Dibenzepin [INN:BAN], Dibenzepine [INN-French], Dibenzepinum [INN-Latin], Dibenzepina [INN-Spanish], 10-[2-(Dimethylamino)ethyl]-5-methyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one, 10-[2-(Dimethylamino)ethyl]-5,10-dihydro-5-methyl-11H-dibenzo[b,e][1,4]diazepin-11-one; Dibenzepin;HF 1927, 9-[2-(dimethylamino)ethyl]-2-methyl-2,9-diazatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one, NSC169412, NCGC00160395-01, BRN 0894708, UNII-510SJZ1Y6L, SR-05000001528, 10-[2-(Dimethylamino)ethyl]-5,10-dihydro-5-methyl-11-H-dibenzo[b,e][1,4]diazepin-11-one, 10-(2-(DIMETHYLAMINO)ETHYL)-5,10-DIHYDRO-5-METHYL-11-H-DIBENZO(B,E)(1,4)DIAZEPIN-11-ONE, Dibenzepin (free base), DIBENZEPIN [MI], Biomol-NT_000090, DIBENZEPIN [WHO-DD], Oprea1_703590, SCHEMBL49286, BPBio1_001093, CHEMBL1442422, SCHEMBL29354805, CHEBI:93394, QPGGEKPRGVJKQB-UHFFFAOYSA-N, HMS2090H08, EX-A2948, BDBM50101814, EBC-26500, MFCD00865354, AKOS023249382, DB13225, FD21524, NCGC00160395-02, NCGC00160395-03, NS00008457, D07812, AB01275527-01, AB01275527_02, EN300-18563712, Q412107, SR-05000001528-1, BRD-K79145749-001-01-8, BRD-K79145749-003-02-2, 5-(2-dimethylaminoethyl)-11-methyl-benzo[b][1,4]benzodiazepin-6-one, 5-[2-(dimethylamino)ethyl]-11-methyl-6-benzo[b][1,4]benzodiazepinone, 5-[2-(dimethylamino)ethyl]-11-methyl-benzo[b][1,4]benzodiazepin-6-one, 10-[2-(Dimethylamino)ethyl]-5,10-dihydro-5-methyl-11H-dibenzo[b,e][1 ,4]diazepin-11-one, 5-Methyl-10b-dimethylaminoethyl-10,11-dihydro -11-oxodibenzo[b,e][1,4]diazepine, 10-[2-(Dimethylamino)ethyl]-5-methyl-5,10-dihydro-11H-dibenzo[b,E][1,4]diazepin-11-one #
Theoretical properties:
molecular_formula: C18H21N3O
molecular_weight: 295.4 g/mol
exact_mass: 295.168462302 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 3
heavy_atom_count: 22
topological_polar_surface_area: 26.8 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: 5-[2-(dimethylamino)ethyl]-11-methyl-6-benzo[b][1,4]benzodiazepinone is a dibenzodiazepine.
chembl: DIBENZEPIN is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. It has similar efficacy and effects relative to other TCAs like imipramine but with fewer side effects.